Archive - Where Tech Meets Bio

12 Startups at the Intersection of AI and Gene Editing

Despite only 1% of biotech VC going to gene editing in 2024, a wave of AI-driven startups is advancing along CRISPR’s clinical milestones

20 hrs ago •

and

Weekly Tech+Bio Highlights #44: New 9.8 Billion Protein Dataset Built for Generative Biology

Rethinking IP in the Age of AI Protein Design, Compressing Medical Images With Clinical Signal Intact, & Where AI in Drug R&D Is (and Isn’t) Gaining…

Jun 16 •

and

Weekly Tech+Bio Highlights #43: New Foundation Model from MIT & Recursion

Also: Spatial Biology Means Terabyte-Scale Files, A Visual Guide to Genome Editors, Biotech VC Enters Quieter Phase, & Why AI Hallucinations May Be a…

Jun 9 •

and

17 More Biomedical AI Foundation Models

MIT & Recursion's Boltz-2 just launched—here’s a fresh scan of 15+ new models spanning chemistry, oncology, trials, and clinical workflows

Jun 7 •

and

Weekly Tech+Bio Highlights #42: Proteins, the Universe, and Everything

Neuralink's $650M Raise, Interactive Map of Digital-Pathology Deals, ASCO AI Highlights, and a 10-Year Quest to Map Cell Behavior

Jun 2 •

and

May 2025

14 Startups in AI Protein Design: Platforms, Specialists, Modular Tools

How a 2024’s Nobel in Chemistry, 200 million predicted structures, and $1 billion startup round shape the new fold of protein design

May 29 •

and

Weekly Tech+Bio Highlights #41: Fortnight Overview

AI Benchmarks, Models, & Gene Editing Startups—$700M+ in New Biotech Funding

May 26 •

and

AI Meets Clinical Trials: Recent Policy Shifts & Companies to Watch

Today, clinical trials are longer and more data-heavy than a decade ago. At a time of regulatory rethinking, we trace how AI is beginning to orchestrate…

May 20 •

Weekly Tech+Bio Highlights #40: FDA Sets Deadline for Internal AI Rollout

Also: Foundation Models & Drug‑Discovery Economics, Structuring Meaning for AI with Ontologies, & Emerging Startups

May 12 •

and

Weekly Tech+Bio Highlights #39: Towards Human-Based Models

Also: AI News, NIH's Policy Shift & What Clinical AI Struggles With

May 5 •

and

The Infrastructure Layer: Platforms Powering Human-Relevant Drug Development

Infrastructure for large-scale biomedical data—from multi-omics to EHRs—is converging with a growing policy and business case for data-native drug…

May 2 •

April 2025

Weekly Tech+Bio Highlights #38: Predictive Models & Benchmarks

Also: Two-Hour Zebrafish Brain Benchmark, BCI Patent Landscape, & Steering Complex Structure Predictions

Apr 28 •

and

#nojs-banner { position: fixed; bottom: 0; left: 0; padding: 16px 16px 16px 32px; width: 100%; box-sizing: border-box; background: red; color: white; font-family: -apple-system, "Segoe UI", Roboto, Helvetica, Arial, sans-serif, "Apple Color Emoji", "Segoe UI Emoji", "Segoe UI Symbol"; font-size: 13px; line-height: 13px; } #nojs-banner a { color: inherit; text-decoration: underline; } This site requires JavaScript to run correctly. Please turn on JavaScript or unblock scripts